JBT MAREL Corp
For the period ended Mar 31, 2025. Filed May 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 5, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. FINANCIAL STATEMENTS
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
| Three Months EndedMarch 31, | ||
|---|---|---|
| (In millions, except per share data) | 2025 | 2024 |
| Revenue: | ||
| Product revenue | $771.1 | $355.4 |
| Service revenue | 83.0 | 36.9 |
| Total revenue | 854.1 | 392.3 |
| Operating expenses: | ||
| Cost of products | 492.2 | 230.5 |
| Cost of services | 69.4 | 21.5 |
| Selling, general and administrative expense | 281.7 | 103.7 |
| Research and development | 33.6 | 6.4 |
| Restructuring expense | 10.6 | 1.1 |
| Operating (loss) income | (33.4) | 29.1 |
| Pension expense, other than service cost | 146.8 | 1.0 |
| Other income | 2.0 | — |
| Interest income | 1.4 | 5.7 |
| Interest expense | 42.4 | 2.9 |
| (Loss) income from continuing operations before income taxes | (219.2) | 30.9 |
| Income tax (benefit) provision | (46.2) | 8.1 |
| Equity in net earnings of unconsolidated affiliate | — | (0.1) |
| (Loss) income from continuing operations | (173.0) | 22.7 |
| Income from discontinued operations, net of taxes | — | 0.1 |
| Net (loss) income | $(173.0) | $22.8 |
| Basic (loss) earnings per share from: | ||
| Continuing operations | $(3.35) | $0.71 |
| Discontinued operations | — | — |
| Net (loss) income | $(3.35) | $0.71 |
| Diluted (loss) earnings per share from: | ||
| Continuing operations | $(3.35) | $0.71 |
| Discontinued operations | — | — |
| Net (loss) income | $(3.35) | $0.71 |
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
| Three Months EndedMarch 31, | ||
|---|---|---|
| (In millions) | 2025 | 2024 |
| Net (loss) income | $(173.0) | $22.8 |
| Other comprehensive income, net of taxes | ||
| Foreign currency translation adjustments | 153.5 | (18.3) |
| Pension and other postretirement benefits adjustments | 112.1 | 0.6 |
| Derivatives designated as hedges | (19.6) | (0.9) |
| Other comprehensive income | 246.0 | (18.6) |
| Comprehensive income | $73.0 | $4.2 |
CONDENSED CONSOLIDATED BALANCE SHEETS
| (In millions, except per share data and number of shares) | March 31, 2025 | December 31, 2024 |
|---|---|---|
| Assets: | ||
| Current Assets: | ||
| Cash and cash equivalents | $101.0 | $1,228.4 |
| Restricted cash | 18.0 | — |
| Trade receivables, net of allowances | 399.3 | 239.7 |
| Contract assets | 144.6 | 95.4 |
| Inventories | 613.5 | 233.1 |
| Other current assets | 212.1 | 66.7 |
| Total current assets | 1,488.5 | 1,863.3 |
| Property, plant and equipment, net of accumulated depreciation of $340.7 and $320.4 respectively | 742.9 | 233.7 |
| Goodwill | 2,834.1 | 769.1 |
| Intangible assets, net | 2,621.9 | 340.9 |
| Other assets | 311.9 | 206.8 |
| Total Assets | $7,999.3 | $3,413.8 |
| Liabilities and Stockholders' Equity: | ||
| Current Liabilities: | ||
| Short-term debt | $21.4 | $— |
| Accounts payable, trade and other | 282.2 | 131.0 |
| Advance and progress payments | 496.1 | 194.1 |
| Accrued payroll | 149.5 | 55.3 |
| Other current liabilities | 234.2 | 155.1 |
| Total current liabilities | 1,183.4 | 535.5 |
| Long-term debt | 1,966.1 | 1,252.1 |
| Accrued pension and other postretirement benefits, less current portion | 16.2 | 19.3 |
| Deferred tax liabilities | 593.2 | 22.1 |
| Other liabilities | 133.1 | 40.6 |
| Commitments and contingencies (Note 13) | ||
| Stockholders' Equity: | ||
| Preferred stock, $0.01 par value; 20,000,000 shares authorized; no shares issued in 2025 or 2024 | — | — |
| Common stock, $0.01 par value; 120,000,000 shares authorized; March 31, 2025: 51,964,035 issued, and 51,964,035 outstanding; December 31, 2024: 31,861,680 issued, and 31,843,794 outstanding | 0.5 | 0.3 |
| Common stock held in treasury, at cost March 31, 2025: 0 shares; December 31, 2024: 17,886 shares | — | (1.8) |
| Additional paid-in capital | 2,727.3 | 234.3 |
| Retained earnings | 1,358.0 | 1,535.9 |
| Accumulated other comprehensive loss | 21.5 | (224.5) |
| Total stockholders' equity | 4,107.3 | 1,544.2 |
| Total Liabilities and Stockholders' Equity | $7,999.3 | $3,413.8 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| Three Months Ended March 31, | ||
|---|---|---|
| (In millions) | 2025 | 2024 |
| Cash flows from continuing operating activities: | ||
| Net (loss) income | $(173.0) | $22.8 |
| Income from discontinued operations, net of taxes | — | 0.1 |
| (Loss) income from continuing operations | (173.0) | 22.7 |
| Adjustments to reconcile (loss) income from continuing operations to cash provided by continuing operating activities: | ||
| Depreciation and amortization | 60.6 | 22.1 |
| Stock-based compensation | 4.8 | 4.2 |
| Pension and other post-retirement benefits expense | 147.1 | 1.3 |
| Other | 27.0 | 1.1 |
| Changes in operating assets and liabilities: | ||
| Trade receivables, net and contract assets | 18.0 | (14.2) |
| Inventories | (12.9) | (13.2) |
| Accounts payable, trade and other | 20.9 | 8.6 |
| Advance and progress payments | 31.8 | (7.9) |
| Accrued pension and other post-retirement benefits, net | (2.8) | (0.3) |
| Other assets and liabilities, net | (87.1) | (14.0) |
| Cash provided by continuing operating activities | 34.4 | 10.4 |
| Cash flows from continuing investing activities: | ||
| Acquisitions, net of cash acquired | (1,746.0) | — |
| Proceeds from sale of AeroTech, net | (0.2) | 2.8 |
| Capital expenditures | (20.0) | (10.5) |
| Proceeds from disposal of assets | 0.6 | 0.5 |
| Cash required by continuing investing activities | (1,765.6) | (7.2) |
| Cash flows from continuing financing activities: | ||
| Net proceeds (payments) on short-term debt | 12.4 | — |
| Repayment of domestic credit facility | (852.5) | — |
| Net proceeds from domestic credit facility, net of debt issuance costs | 664.9 | — |
| Proceeds from Term Loan B, net of debt issuance costs | 890.4 | — |
| Payment of other debt issuance costs related to the Marel Transaction | (13.7) | — |
| Acquisition of noncontrolling interest of Marel | (24.4) | — |
| Settlement of taxes withheld on stock-based compensation awards | (7.6) | (2.9) |
| Settlement of deal contingent hedge | (42.5) | — |
| Dividends | (5.3) | (3.2) |
| Other | (0.3) | — |
| Cash provided (required) by continuing financing activities | 621.4 | (6.1) |
| Net decrease in cash from continuing operations | (1,109.8) | (2.9) |
| Cash flows from discontinued operations: | ||
| Cash required by operating activities of discontinued operations, net | — | (0.2) |
| Net cash required by discontinued operations | — | (0.2) |
| Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash | 0.4 | (1.2) |
| Net decrease in cash, cash equivalents and restricted cash | (1,109.4) | (4.3) |
| Cash, cash equivalents, and restricted cash from continuing operations, beginning of period | 1,228.4 | 483.3 |
| Add: Cash, cash equivalents and restricted cash from discontinued operations, beginning of period | — | — |
| Add: Net decrease in cash, cash equivalents and restricted cash | (1,109.4) | (4.3) |
| Less: Cash, cash equivalents and restricted cash from discontinued operations, end of period | — | — |
| Cash, cash equivalents and restricted cash from continuing operations, end of period | $119.0 | $479.0 |
| Three Months Ended March 31, | ||
|---|---|---|
| (In millions) | 2025 | 2024 |
| Supplemental cash flow information for continuing operations: | ||
| Non-cash investing in capital expenditures, accrued but not paid | $0.3 | $3.3 |
| Reconciliation of cash, cash equivalents and restricted cash | ||
| Cash and cash equivalents | $101.0 | $479.0 |
| Restricted cash | 18.0 | — |
| Total cash, cash equivalents and restricted cash shown in the consolidated statements of cash flows | $119.0 | $479.0 |
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
| Three Months Ended March 31, 2025 | ||||||
|---|---|---|---|---|---|---|
| (In millions) | Common Stock | Common Stock Held in Treasury | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Total Equity |
| Balance at December 31, 2024 | $0.3 | $(1.8) | $234.3 | $1,535.9 | $(224.5) | $1,544.2 |
| Net loss | — | — | — | (173.0) | — | (173.0) |
| Issuance of common stock | 0.2 | — | 2,497.6 | — | — | 2,497.8 |
| Issuance of treasury stock | — | 1.8 | (1.8) | — | — | — |
| Common stock cash dividends, $0.10 per share | — | — | — | (5.1) | — | (5.1) |
| Foreign currency translation adjustments | — | — | — | — | 153.5 | 153.5 |
| Derivatives designated as hedges, net of income taxes of $6.8 | — | — | — | — | (19.6) | (19.6) |
| Pension and other postretirement liability adjustments, net of income taxes of $(37.9) | — | — | — | — | 112.1 | 112.1 |
| Stock-based compensation expense | — | — | 4.8 | — | — | 4.8 |
| Taxes withheld on issuance of stock-based awards | — | — | (7.6) | — | — | (7.6) |
| Other | — | — | — | 0.2 | — | 0.2 |
| Balance at March 31, 2025 | $0.5 | $— | $2,727.3 | $1,358.0 | $21.5 | $4,107.3 |
| Three Months Ended March 31, 2024 | ||||||
|---|---|---|---|---|---|---|
| (In millions) | Common Stock | Common Stock Held in Treasury | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Total Equity |
| Balance at December 31, 2023 | $0.3 | $(7.1) | $227.9 | $1,463.6 | $(195.8) | $1,488.9 |
| Net income | — | — | — | 22.8 | — | 22.8 |
| Issuance of treasury stock | — | 3.9 | (3.9) | — | — | — |
| Common stock cash dividends, $0.10 per share | — | — | — | (3.3) | — | (3.3) |
| Foreign currency translation adjustments | — | — | — | — | (18.3) | (18.3) |
| Derivatives designated as hedges, net of income taxes of $0.3 | — | — | — | — | (0.9) | (0.9) |
| Pension and other postretirement liability adjustments, net of income taxes of $(0.4) | — | — | — | — | 0.6 | 0.6 |
| Stock-based compensation expense | — | — | 4.2 | — | — | 4.2 |
| Taxes withheld on issuance of stock-based awards | — | — | (2.9) | — | — | (2.9) |
| Balance at March 31, 2024 | $0.3 | $(3.2) | $225.3 | $1,483.1 | $(214.4) | $1,491.1 |
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION
Description of Business
JBT Marel Corporation and its majority-owned consolidated subsidiaries (the “Company,” “JBT Marel,” “our,” “us,” or “we”) provide global technology solutions to high-value segments of the food and beverage industry. The Company designs, produces and services sophisticated products and systems for multi-national and regional customers. The Company has manufacturing operations worldwide that are strategically located to facilitate delivery of its products and services to its customers.
Basis of Presentation
In accordance with Securities and Exchange Commission (“SEC”) rules for interim periods, the accompanying unaudited condensed consolidated financial statements (the “interim financial statements”) do not include all of the information and notes for complete financial statements as required by accounting principles generally accepted in the United States of America (“U.S. GAAP”). As such, the accompanying interim financial statements should be read in conjunction with the Annual Report on Form 10-K for the year ended December 31, 2024, which provides a more complete description of the Company’s accounting policies, financial position, operating results, business, properties, and other matters. The year-end Condensed Consolidated Balance Sheet was derived from audited financial statements, but does not include all annual disclosures required by accounting principles generally accepted in the United States of America.
In the opinion of management, the interim financial statements reflect all normal recurring adjustments necessary for a fair statement of the Company's financial condition and operating results as of and for the periods presented. Revenue, expenses, assets and liabilities can vary during each quarter of the year. Therefore, the interim results and trends in the interim financial statements may not be representative of those for the full year or any future period.
Strategic Acquisition of Marel hf.
On January 2, 2025, the Company completed the previously announced acquisition of Marel hf. ("Marel"). Refer to Note 2. Acquisitions for additional information on the acquisition of Marel.
Business Segments
Following the acquisition of Marel on January 2, 2025, the Company has determined that it hastwo reportable segments: the legacy pre-acquisition operations of the Company ("JBT") and the acquired entity of Marel. The JBT segment provides comprehensive solutions throughout the food production value chain for a variety of food and beverage groups, in addition to providing automated guided vehicle systems. The Marel segment provides advanced processing equipment, systems, software, and services, primarily for the poultry, meat, and fish industries, as well as processing solutions for pet food, plant-based proteins and aqua feed.
The Company is in the process of integrating the businesses and establishing internal reporting capabilities and in the future will realign its reportable segments.
Use of Estimates
Preparation of financial statements that follow U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates.
Restricted Cash
Restricted cash is recorded at fair value (Level 1 fair value measurement) and consists of money market securities, intended to fund one of the Company's employee deferred compensation plans.
Recently Issued Accounting Standards Not Yet Adopted
In December 2023, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") 2023-09, Income Taxes - Improvements to Income Tax Disclosures ("ASU 2023-09"), which amends Topic 740, Income Taxes. ASU 2023-09 improves the transparency of income tax disclosures by requiring (1) consistent categories and greater disaggregation of information in the rate reconciliation and (2) income taxes paid disaggregated by jurisdiction. It also includes certain other amendments to improve the effectiveness of income tax disclosures. The amendments in ASU 2023-09 are effective for the Company for the fiscal year beginning January 1, 2025, and for interim periods beginning on and after January 1, 2026, and will be applied on a prospective basis. The Company expects ASU 2023-09 to impact its disclosures only.
In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses ("ASU 2024-03"), that requires disclosures of disaggregated information about certain income statement expense line items on an annual and interim basis. This standard is effective for fiscal years beginning after December 15, 2026, with early adoption permitted, and will be applied prospectively, with the option to apply retrospectively. The Company expects ASU 2024-03 to impact its disclosures only and is currently evaluating the impact of adopting this standard.
NOTE 2. ACQUISITIONS
On January 2, 2025, the Company acquired 97.5% of the equity interests of Marel hf. ("Marel"), a public limited liability company incorporated under the laws of Iceland, for $4,182.3 million, which is net of cash acquired of $90.0 million (the "Marel Transaction"). Marel is a global provider of advanced processing equipment, systems, software and services, primarily for the poultry, meat, and fish industries, as well as a provider of processing solutions for pet food, plant-based proteins and aqua feed, with a presence in over 30 countries. The purpose of the acquisition of Marel was to create a leading and diversified global food and beverage technology solutions provider by bringing together two renowned companies with complementary product portfolios, highly respected brands, and cutting-edge technology to enable global customers to more efficiently access industry leading technology worldwide.
As part of the Marel Transaction, the Company settled Marel's outstanding debt of $867.8 million. In addition, the Company amended its existing credit facility in conjunction with the acquisition. The Second Amended and Restated Credit Agreement provides for a $1.8 billion revolving credit facility which matures on January 2, 2030, and a $900.0 million Senior Secured Term Loan B which matures on January 2, 2033. The proceeds from these facilities were used to fund the cash consideration for the acquisition and to settle the outstanding debt of Marel at the acquisition date.
The consideration transferred to Marel shareholders on the acquisition date consisted of the following:
| (In millions, except per share data and exchange rates) | |
|---|---|
| JBT shares issued to Marel shareholders | 19.5 |
| JBT share price on January 2, 2025 | $124.94 |
| Value of JBT shares issued to Marel shareholders | $2,436.3 |
| Cash consideration to Marel shareholders (in €) | €926.6 |
| EUR to USD Exchange Rate | 1.0353 €/$ |
| Cash consideration to Marel shareholders (in $) | $959.3 |
| Settlement of Marel debt | $867.8 |
| Settlement of Marel interest rate swaps | $3.3 |
| Fair value of Marel stock options attributable to pre-combination vesting | $5.6 |
| Purchase consideration | $4,272.3 |
This acquisition has been accounted for as a business combination. Tangible and identifiable intangible assets acquired and liabilities assumed were recorded at their respective estimated fair values. The excess consideration over the estimated fair value of the net assets received has been recorded as goodwill. The factors that contributed to the recognition of goodwill primarily relate to acquisition-driven anticipated cost savings and revenue enhancement synergies coupled with the assembled workforce acquired. Assembled workforce is not recognized separate and apart from goodwill as it is neither separable nor contractual in nature. Goodwill created as a result of the Marel acquisition is not deductible for tax purposes.
Marel had revenue of $445.3 million and generated operating income of $1.0 million for the period from the acquisition date through March 31, 2025.
Acquisition-related transaction costs totaling $63.8 million were recorded as Selling, general and administrative expense in the Condensed Consolidated Statements of Income during the three months ended March 31, 2025.
The purchase accounting for Marel is provisional as the valuation of certain intangible and long-term assets, working capital balances, other assets and liabilities, income tax balances, and residual goodwill related to this acquisition is not complete. The fair values assigned to tangible and intangible assets acquired and liabilities assumed are preliminary based on management’s estimates and assumptions and may be subject to change as additional information is received. These amounts are subject to adjustment as additional information is obtained within the measurement period (not to exceed 12 months from the acquisition date).
The following table summarizes the provisional fair values recorded for the assets acquired and liabilities assumed for Marel:
| (In millions) | |
|---|---|
| Financial assets | $401.8 |
| Inventories | 344.4 |
| Property, plant and equipment | 492.6 |
| Right-of-use assets | 42.3 |
| Customer relationship | 1,570.0 |
| Patents and acquired technology | 410.0 |
| Trademarks | 260.0 |
| Deferred taxes | (514.9) |
| Financial liabilities | (630.0) |
| Total identifiable net assets | $2,376.2 |
| Purchase consideration | $4,272.3 |
| Noncontrolling interest(1) | $86.0 |
| Goodwill | $1,982.1 |
(1) The Company acquired 97.5% of the equity interests of Marel and recognized a non-controlling interest in Marel on the acquisition date. The non-controlling interest was recognized at fair value, which was estimated based upon the trading price of the Company’s common stock on the acquisition date and the types of consideration that non-controlling interest holders were eligible to receive.
The following table summarizes information regarding preliminary identifiable assets acquired:
| (In millions, except useful life) | Estimated Useful Lives | Preliminary Estimated Asset Fair Value |
|---|---|---|
| Customer relationships | 19 | $1,570.0 |
| Patents and acquired technology | 19 | 410.0 |
| Trademarks | 29 | 260.0 |
| Total intangible assets acquired | $2,240.0 |
The allocation of the purchase price presented above was based on management's preliminary estimate of the fair values of the acquired assets and assumed liabilities using valuation techniques including the income, market, and cost approaches.
Pro forma financial information (unaudited)
The following information reflects the results of the Company’s operations for the three months ended March 31, 2025 and March 31, 2024 on a pro forma basis as if the acquisition of Marel had been completed on January 1, 2024. Pro forma adjustments have been made to illustrate the impact of incremental non-recurring acquisition-related costs totaling $91.0 million, and the incremental impact on earnings of interest costs on the borrowings to acquire the company, amortization expense related to acquired intangible assets, depreciation expense related to the fair value of the acquired depreciable tangible assets, and the related tax impact associated with these adjustments.
| For the three months ended March 31, | ||
|---|---|---|
| (In millions, except per share data) | 2025 | 2024 |
| Revenue | ||
| Pro forma | $854.1 | $840.8 |
| Income from continuing operations | ||
| Pro forma | $(122.8) | $(111.7) |
The unaudited pro forma information is provided for illustrative purposes only and does not purport to represent what the Company's consolidated results of operations would have been had the transaction actually occurred as of January 1, 2024, and does not purport to project actual consolidated results of operations.
Acquisition of non-controlling interest of Marel
On February 4, 2025, the Company acquired the remaining 2.5% of Marel’s equity interests that were not acquired through the Marel Transaction, for approximately $88.7 million. The total purchase consideration was comprised of approximately $64.3 million in equity consideration and $24.4 million in cash consideration. This transaction was accounted for as an equity transaction and was reflected within financing activities within the Consolidated Statement of Cash Flows.
NOTE 3. GOODWILL AND INTANGIBLE ASSETS
The changes in the carrying amount of goodwill by business segment were as follows:
| (In millions) | JBT | Marel | Total |
|---|---|---|---|
| Balance as of December 31, 2024 | $769.1 | $— | $769.1 |
| Acquisitions | — | 1,982.1 | 1,982.1 |
| Currency translation | 7.8 | 75.1 | 82.9 |
| Balance as of March 31, 2025 | $776.9 | $2,057.2 | $2,834.1 |
Intangible assets consisted of the following:
| March 31, 2025 | December 31, 2024 | |||
|---|---|---|---|---|
| (In millions) | Carrying Amount | Accumulated Amortization | Carrying Amount | Accumulated Amortization |
| Customer relationship | $2,065.4 | $200.1 | $421.3 | $170.6 |
| Patents and acquired technology | 577.3 | 137.7 | 169.8 | 123.1 |
| Trademarks | 326.0 | 23.4 | 53.2 | 20.0 |
| Non-amortizing intangible assets | 10.4 | — | 10.3 | — |
| Other | 10.0 | 6.0 | 8.6 | 8.6 |
| Total intangible assets | $2,989.1 | $367.2 | $663.2 | $322.3 |
Intangible asset amortization expense was $42.4 million and $14.5 million for the three months ended March 31, 2025 and 2024, respectively. Annual amortization expense for intangible assets is estimated to be $155.2 million in 2025, $153.4 million in 2026, $149.5 million in 2027, $147.4 million in 2028, and $143.9 million in 2029.
NOTE 4. INVENTORIES
Inventories consisted of the following:
| (In millions) | March 31, 2025 | December 31, 2024 |
|---|---|---|
| Raw materials | $197.4 | $37.3 |
| Work in process | 90.9 | 50.2 |
| Finished goods | 351.5 | 164.9 |
| Gross inventories before valuation adjustments | 639.8 | 252.4 |
| Valuation adjustments | (26.3) | (19.3) |
| Net inventories | $613.5 | $233.1 |
NOTE 5. PENSION
Components of net periodic benefit cost were as follows:
| Three Months Ended March 31, | ||
|---|---|---|
| (In millions) | 2025 | 2024 |
| Service cost | $0.3 | $0.3 |
| Interest cost | 0.4 | 3.1 |
| Expected return on plan assets | (0.5) | (3.5) |
| Amortization of net actuarial losses | — | 1.4 |
| Settlement charge recognized | 146.9 | — |
| Net periodic cost | $147.1 | $1.3 |
During the three months ended March 31, 2025, the Company made contributions of $2.9 million to its pension plans and expects to contribute $5.4 million in 2025, primarily to its non-U.S. pension plans.
Termination of U.S. qualified defined benefit pension plan
During 2024, the Company obtained approval from its Board of Directors to settle all outstanding obligations of the U.S. qualified defined benefit pension plan (the “Plan”), through a combination of voluntary lump sum payments and the purchase of an annuity contract. On February 4, 2025, the Company completed the termination of the Plan via the purchase of an annuity contract for $178.5 million, funded entirely by the Plan assets. No additional cash contribution was required to settle the Company's outstanding obligations and terminate the Plan.
The final settlement of the Plan triggered a remeasurement of the related plan benefit obligation and assets as of February 4, 2025. The net effect of the Plan remeasurement was an increase in the net funded status of the Plan of $3.4 million primarily due to an increase in the discount rate used to value to the pension liability and assets. Upon the termination, the Company recognized a pre-tax settlement charge of $146.9 million in Pension expense, other than service cost to recognize the remaining pre-tax accumulated other comprehensive loss related to the Plan.
NOTE 6. DEBT
The components of the Company's borrowings were as follows:
| (In millions) | Maturity Date | March 31, 2025 | December 31, 2024 |
|---|---|---|---|
| Revolving credit facility (1) | January 2, 2030 | $691.7 | $854.0 |
| Senior Secured Term Loan B (2) | January 2, 2032 | 900.0 | — |
| Convertible senior notes (3) | May 15, 2026 | 402.5 | 402.5 |
| Less: unamortized debt issuance costs | (19.1) | (4.4) | |
| Total debt, including current portion | 1,975.1 | 1,252.1 | |
| Less: current portion of long-term debt | 9.0 | — | |
| Long-term debt, net | $1,966.1 | $1,252.1 |
(1) Weighted-average interest rate at March 31, 2025 was 6.25%.
(2) Effective interest rate at March 31, 2025 was 6.67%.
(3) Effective interest rate for the Notes (as defined below) for the quarter ended March 31, 2025 was 0.82%.
The Company had access to short-term financing of $62.5 million and $8.0 million as of March 31, 2025 and December 31, 2024, respectively.
Components of interest expense recognized for the Senior Secured Term Loan B (the "Term Loan B") and the 0.25% Convertible Senior Notes due 2026 (the "Notes") were as follows:
| Three Months EndedMarch 31, | ||
|---|---|---|
| (In millions) | 2025 | 2024 |
| Contractual interest expense, Term Loan B | $14.7 | $— |
| Interest cost related to amortization of issuance costs, Term Loan B | 0.5 | — |
| Total interest expense, Term Loan B | $15.2 | $— |
| Contractual interest expense, the Notes | $0.3 | $0.3 |
| Interest cost related to amortization of issuance costs, the Notes | 0.6 | 0.6 |
| Total interest expense, the Notes | $0.9 | $0.9 |
Five-year Revolving Credit Facility
On January 2, 2025, the Company executed the Second Amended and Restated Credit Agreement (the "Second A&R Credit Agreement"), which extended the maturity date of the previous credit agreement from December 2026 to January 2030 and increased the Company's borrowing limit from $1.3 billion to $1.8 billion. The commitments under the Second A&R Credit Agreement terminate on January 2, 2030; provided that if (1) any of the Company’s Convertible Senior Notes remain outstanding on the date that is 91 days prior to the maturity date of the Convertible Notes (the “Springing Maturity Date”), (2) the aggregate principal amount of the Convertible Notes outstanding on such date exceeds $100 million and (3) the sum of the aggregate availability under the Second A&R Credit Agreement on such date plus the aggregate amount of unrestricted cash of the Company and its subsidiaries on such date is less than $600 million, then the maturity date with respect to the revolving credit facility shall be the Springing Maturity Date.
Under the Second A&R Credit Agreement, the Company is subject to a maximum Secured Net Leverage Ratio (as defined in the Second A&R Credit Agreement) for the first 12 months after the closing of the Marel Transaction of 5.00 to 1.00, stepping down to 4.00 to 1.00 at 12 months after the closing of the Marel Transaction and further stepping down to 3.50 to 1.00 at 18 months after the closing of the Marel Transaction. Among other things, the Second A&R Credit Agreement allows the Company the option to temporarily increase the maximum allowable Secured Net Leverage Ratio to 4.00 to 1.00 following the completion of a permitted acquisition, or a series of permitted acquisitions within a 12-month period (other than the Marel Transaction), having aggregate consideration in excess of $100 million (the "Leverage Ratio Increase Option"). If exercised, the Leverage Ratio Increase Option will remain in effect for four consecutive fiscal quarters (beginning with the quarter in which the permitted acquisition, or the last permitted acquisition in a series of permitted acquisitions for aggregate consideration in excess of $100 million, is consummated), unless revoked earlier by the Company.
The Second A&R Credit Agreement also provides that, solely with respect to the revolving credit facility thereunder, the Company is subject to an Interest Coverage Ratio (as defined in the Second A&R Credit Agreement) of not less than: (a) Consolidated EBITDA (as defined in the Second A&R Credit Agreement) to (b) Consolidated Interest Expense (as defined in the Second A&R Credit Agreement), in each case for the period of four consecutive fiscal quarters ending with the end of such fiscal quarter, all calculated for the Company and its subsidiaries on a consolidated basis, to be less than: (1) for the first 18 months after the closing date of the Marel Transaction,2.50 to 1.00 and (2) thereafter,3.00 to 1.00.
Revolving loans under the credit facility bear interest at the Company's option, at 1) SOFR (subject to a floor rate ofzero) plus 10 basis points, or 2) an alternative base rate (which is the greater of Wells Fargo’s Prime Rate, the Federal Funds Rate plus 50 basis points, or SOFR (subject to a floor rate of zero) plus 1.1%), plus, in each case, a margin dependent on the leverage ratio.
Senior Secured Term Loan B
The Second A&R Credit Agreement also provided for aseven-year Senior Secured Term Loan B (the "Term Loan B") in an aggregate principal amount of $900 million. The entire amount of the Term Loan B was funded on January 2, 2025 and matures in January 2032. The Company is required to make quarterly principal repayments equal to 0.25% of the initial Term Loan B, beginning in the second quarter of 2025. Borrowings under the Term Loan B bear interest at the greater of 1) SOFR plus 10 basis points, or 2) a floor of 0%, plus an applicable margin of 200 basis points to 225 basis points, dependent on the leverage ratio.
During the three months ended March 31, 2025, the Company recognized $2.3 million of financing costs associated with the Term Loan B, which were recorded in other assets on the Balance Sheets at March 31, 2025.
Convertible Note Hedge Transactions
On May 28, 2021, the Company closed a private offering of $402.5 million aggregate principal amount of the Notes to qualified institutional buyers. The initial conversion rate of the Notes is 5.8958 shares of the Company's common stock per $1,000 principal amount of notes, which is equivalent to an initial conversion price of approximately $169.61 per share. The conversion rate of the Notes is subject to adjustment upon the occurrence of certain specified events.
On May 28, 2021, the Company paid an aggregate amount of $65.6 million for the Convertible Note Hedge Transactions (the "Hedge Transactions"). The Hedge Transactions cover, subject to anti-dilution adjustments substantially similar to those in the Notes, approximately 2.4 million shares of the Company's common stock. These are the same number of shares initially underlying the Notes, at a strike price of $169.61, subject to customary adjustments. The Hedge Transactions will expire upon the maturity of the Notes, subject to earlier exercise or termination.
The Hedge Transactions are expected generally to reduce the potential dilutive effect of the conversion of the Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of the converted Notes, in the event that the market price per share of the Company's common stock, as measured under the terms of the Hedge Transactions, is greater than the Hedge Transactions strike price of $169.61. The Hedge Transactions meet the criteria in ASC 815-40 to be classified within Stockholders' Equity, and therefore these transactions are not revalued after their issuance.
The Company made a tax election to integrate the Notes and the Hedge Transactions. The accounting impact of this tax election makes the Hedge Transactions deductible as original issue discount interest for tax purposes over the term of the note, and results in a $17.1 million deferred tax asset recorded as an adjustment to Additional paid-in capital on our Condensed Consolidated Balance Sheet as of March 31, 2025.
Warrant Transactions
Concurrently with entering into the Hedge Transactions, the Company separately entered into privately-negotiated Warrant Transactions (the "Warrant Transactions"), whereby the Company sold to the counterparties warrants to acquire, collectively, subject to anti-dilution adjustments,2.4 million shares of its common stock at an initial strike price of $240.02 per share. The Company received aggregate proceeds of $29.5 million from the Warrant Transactions with the counterparties, with such proceeds partially offsetting the costs of entering into the Hedge Transactions. The warrants expire in August 2026. If the market value per share of the common stock, exceeds the strike price of the warrants, the warrants will have a dilutive effect on our earnings per share, unless the Company elects, subject to certain conditions, to settle the warrants in cash. The warrants meet the criteria in ASC 815-40 to be classified within Stockholders' Equity, and therefore the warrants are not revalued after issuance.
NOTE 7. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
Accumulated other comprehensive income or loss (“AOCI”) represents the cumulative balance of other comprehensive income, net of tax, as of the balance sheet date. For the Company, AOCI is composed of adjustments related to pension and other postretirement benefit plans, derivatives designated as hedges, and foreign currency translation adjustments. Changes in the AOCI balances for the three months ended March 31, 2025 and 2024 by component are shown in the following tables:
| (In millions) | Pension and Other Postretirement Benefits (1) | Derivatives Designated as Hedges (1) | Foreign Currency Translation | Total (1) |
|---|---|---|---|---|
| Beginning balance, December 31, 2024 | $(113.5) | $2.1 | $(113.1) | $(224.5) |
| Other comprehensive income before reclassification | 2.3 | (16.5) | 153.5 | 139.3 |
| Amounts reclassified from accumulated other comprehensive income | 109.8 | (3.1) | — | 106.7 |
| Ending balance, March 31, 2025 | $(1.4) | $(17.5) | $40.4 | $21.5 |
(1) All amounts are net of income taxes.
Reclassification adjustments from AOCI into earnings for pension and other postretirement benefit plans for the three months ended March 31, 2025 were $146.9 million of charges to pension expense, other than service cost, net of $37.1 million in benefit for income taxes. Reclassification adjustments for derivatives designated as hedges for the same period were $2.2 million of benefit in interest expense, net of $0.6 million income tax provision and $2.0 million of benefit in other income, net of $0.5 million income tax provision.
| (In millions) | Pension and Other Postretirement Benefits (1) | Derivatives Designated as Hedges (1) | Foreign Currency Translation (1) | Total (1) |
|---|---|---|---|---|
| Beginning balance, December 31, 2023 | $(132.7) | $9.2 | $(72.3) | $(195.8) |
| Other comprehensive income before reclassification | (0.4) | 1.3 | (18.3) | (17.4) |
| Amounts reclassified from accumulated other comprehensive income | 1.0 | (2.2) | — | (1.2) |
| Ending balance, March 31, 2024 | $(132.1) | $8.3 | $(90.6) | $(214.4) |
(1) All amounts are net of income taxes.
Reclassification adjustments from AOCI into earnings for pension and other postretirement benefit plans for the three months ended March 31, 2024 were $1.4 million of charges to pension expense, other than service cost, net of $0.4 million income tax benefit. Reclassification adjustments for derivatives designated as hedges for the same period were $2.9 million of benefit in interest expense, net of $0.7 million income tax provision.
NOTE 8. REVENUE RECOGNITION
Transaction price allocated to remaining performance obligations
The Company has estimated that $1.3 billion in revenue is expected to be recognized in future periods related to remaining performance obligations from the Company's contracts with customers outstanding as of March 31, 2025. The Company expects to complete these obligations and recognize revenue in the range of 75% to 85% during 2025,10% to 15% during 2026, and the remainder after 2026.
Disaggregation of Revenue
In the following table, revenue is disaggregated by type of good or service, primary geographical market, and timing of recognition. The table also includes a reconciliation of the disaggregated revenue to total revenue.
| Three Months EndedMarch 31, 2025 · Three Months EndedMarch 31, 2024 | |||
|---|---|---|---|
| (In millions) | JBT | Marel | JBT |
| Type of Good or Service | |||
| Recurring (1) | $222.8 | $226.1 | $202.8 |
| Non-recurring (1) | 186.0 | 219.2 | 189.5 |
| Total | 408.8 | 445.3 | 392.3 |
| Geographical Region (2) | |||
| U.S. and Canada | 218.3 | 127.2 | 234.7 |
| Europe, Middle East and Africa | 126.0 | 220.4 | 93.0 |
| Asia Pacific | 31.9 | 45.6 | 32.8 |
| Latin America | 32.6 | 52.1 | 31.8 |
| Total | 408.8 | 445.3 | 392.3 |
(1) Recurring revenue includes revenue from aftermarket parts and services, re-build services on customer owned equipment, operating leases of equipment, and subscription-based software applications. Non-recurring revenue includes new equipment and installation and the sale of software licenses.
(2) Geographical region represents the region in which the end customer resides.
Contract balances
The timing of revenue recognition, billings and cash collections results in trade receivables, contract assets, and advance and progress payments (contract liabilities). Contract assets exist when revenue recognition occurs prior to billings. Contract assets are transferred to trade receivables when the right to payment becomes unconditional (i.e., when receipt of the amount is dependent only on the passage of time). Conversely, the Company often receives payments from its customers before revenue is recognized, resulting in contract liabilities. These assets and liabilities are reported on the Condensed Consolidated Balance Sheets as Contract assets and within Advance and progress payments, respectively, on a contract-by-contract net basis at the end of each reporting period.
Contract asset and liability balances for the period were as follows:
| Balances as of | ||
|---|---|---|
| (In millions) | March 31, 2025 | December 31, 2024 |
| Contract Assets | $144.6 | $95.4 |
| Contract Liabilities | 480.8 | 178.0 |
| March 31, 2024 | December 31, 2023 | |
| Contract Assets | 78.6 | 74.5 |
| Contract Liabilities | 147.4 | 156.5 |
The revenue recognized during the three months ended March 31, 2025 and 2024 that was included in contract liabilities at the beginning of the period amounted to $84.7 million and $72.9 million, respectively. The Company assumed contract liabilities from acquisitions in the amount of $257.1 million in 2025. The remainder of the change from December 31, 2024 and December 31, 2023 is driven by the timing of advance and milestone payments received from customers, customer returns and fulfillment of performance obligations. There were no significant changes in the contract balances other than those described above.
NOTE 9. EARNINGS PER SHARE
The following table sets forth the computation of basic and diluted earnings per share from net (loss) income for the respective periods and basic and diluted shares outstanding:
| Three Months EndedMarch 31, | ||
|---|---|---|
| (In millions, except per share data) | 2025 | 2024 |
| Basic (loss) earnings per share: | ||
| (Loss) income from continuing operations | $(173.0) | $22.7 |
| Income from discontinued operations, net of taxes | — | 0.1 |
| Net (loss) income | $(173.0) | $22.8 |
| Weighted average number of shares outstanding | 51.7 | 32.0 |
| Basic (loss) earnings per share from: | ||
| Continuing operations | $(3.35) | $0.71 |
| Discontinued operations | — | — |
| Net (loss) income | $(3.35) | $0.71 |
| Diluted (loss) earnings per share: | ||
| (Loss) income from continuing operations | $(173.0) | $22.7 |
| Income from discontinued operations, net of taxes | — | 0.1 |
| Net (loss) income | $(173.0) | $22.8 |
| Weighted average number of shares outstanding | 51.7 | 32.0 |
| Effect of dilutive securities: | ||
| Restricted stock(1) | — | 0.2 |
| Total shares and dilutive securities | 51.7 | 32.2 |
| Diluted (loss) earnings per share from: | ||
| Continuing operations | $(3.35) | $0.71 |
| Discontinued operations | — | — |
| Net (loss) income | $(3.35) | $0.71 |
| Restricted stock shares with anti-dilutive effect excluded from the computation of diluted earnings per share(1) | 0.2 | — |
(1) As a result of the net loss recognized for the three months ended March 31, 2025, the effect of unvested equity awards was antidilutive and has been excluded from the diluted earnings per share calculation.
NOTE 10. FAIR VALUE OF FINANCIAL INSTRUMENTS
The fair value framework requires the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment. The three levels are defined as follows:
Level 1: Unadjusted quoted prices in active markets for identical assets and liabilities that the Company can assess at the measurement date.
Level 2: Observable inputs other than those included in Level 1 that are observable for the asset or liability, either directly or indirectly. For example, quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets.
Level 3: Unobservable inputs reflecting management’s own assumptions about the inputs used in pricing the asset or liability.
Financial assets and financial liabilities measured at fair value on a recurring basis are as follows:
| As of March 31, 2025 | As of December 31, 2024 | |||||||
|---|---|---|---|---|---|---|---|---|
| (In millions) | Total | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 |
| Assets: | ||||||||
| Investments | $12.7 | $12.7 | $— | $— | $13.2 | $13.2 | $— | $— |
| Derivatives | 10.7 | — | 10.7 | — | 6.8 | — | 6.8 | — |
| Total assets | $23.4 | $12.7 | $10.7 | $— | $20.0 | $13.2 | $6.8 | $— |
| Liabilities: | ||||||||
| Derivatives | $56.8 | $— | $56.8 | $— | $44.4 | $— | $44.4 | $— |
| Total liabilities | $56.8 | $— | $56.8 | $— | $44.4 | $— | $44.4 | $— |
Investments represent securities held in a trust for the non-qualified deferred compensation plan. Investments are classified as trading securities and are valued based on quoted prices in active markets for identical assets that the Company has the ability to access. As of March 31, 2025, $1.0 million of investments are recorded in Other current assets in the Condensed Consolidated Balance Sheets related to investments that are expected to be redeemed within the next twelve months. The remaining investments are reported separately in Other assets in the Condensed Consolidated Balance Sheets. Investments include an unrealized loss of $0.2 million as of March 31, 2025 and an unrealized gain of $1.1 million as of December 31, 2024.
The Company uses the income approach to measure the fair value of derivative instruments on a recurring basis. This approach calculates the present value of the future cash flow by measuring the change between the derivative contract rate and the published market indicative currency rate, multiplied by the contract notional values, and applying an appropriate discount rate as well as a factor of credit risk.
The Notes are not registered securities nor listed on any securities exchange but may be traded by qualified institutional buyers. The fair value of the Notes estimated using Level 2 inputs was $400.2 million as of March 31, 2025.
The carrying amounts of cash and cash equivalents, trade receivables and payables, marketable securities, as well as financial instruments included in other current assets and other current liabilities, approximate fair values because of their short-term maturities.
The carrying values of the Company's revolving credit facility recorded in long-term debt on the Condensed Consolidated Balance Sheets approximate their fair values due to their variable interest rates.
NOTE 11. DERIVATIVE FINANCIAL INSTRUMENTS AND RISK MANAGEMENT
Derivative financial instruments
All derivatives are recorded as assets or liabilities in the Condensed Consolidated Balance Sheets at their respective fair values. For derivatives designated as cash flow and fair value hedges, the unrealized gain or loss related to the derivatives is recorded in Other comprehensive income (loss) until the hedged transaction affects earnings. The Company assesses at the inception of the hedge, whether the derivative in the hedging transaction will be highly effective in offsetting changes in cash flows or in fair value of the hedged item. Changes in the fair value of derivatives that do not meet the criteria for designation as a hedge are recognized in earnings.
Foreign Exchange: The Company manufactures and sells products in a number of countries throughout the world and, as a result, the Company is exposed to movements in foreign currency exchange rates. The Company's major foreign currency exposures involve the markets in Western Europe, South America and Asia. Some sales and purchase contracts contain embedded derivatives due to the nature of doing business in certain jurisdictions, which the Company takes into consideration as part of its risk management policy. The purpose of foreign currency hedging activities is to manage the economic impact of exchange rate volatility associated with anticipated foreign currency purchases and sales made in the normal course of business. The Company primarily utilizes forward foreign exchange contracts with maturities of less thanone year in managing this foreign exchange rate risk. The Company has not designated these forward foreign exchange contracts, which had a notional value at March 31, 2025 of $423.7 million, as hedges and therefore does not apply hedge accounting.
The fair values of our foreign currency derivative assets are recorded within other current assets and other assets, and the fair values of foreign currency derivative liabilities are recorded within other current liabilities and other liabilities. The following table presents the fair value of foreign currency derivatives and embedded derivatives included within the Condensed Consolidated Balance Sheets:
| As of March 31, 2025 | As of December 31, 2024 | |||
|---|---|---|---|---|
| (In millions) | Derivative Assets | Derivative Liabilities | Derivative Assets | Derivative Liabilities |
| Total | $9.9 | $3.3 | $3.8 | $44.4 |
A master netting arrangement allows counterparties to net settle amounts owed to each other as a result of separate offsetting derivative transactions. The Company enters into master netting arrangements with its counterparties when possible to mitigate credit risk in derivative transactions by permitting it to net settle for transactions with the same counterparty. However, the Company does not net settle with such counterparties. As a result, derivatives are presented at their gross fair values in the Condensed Consolidated Balance Sheets.
As of March 31, 2025 and December 31, 2024, information related to these offsetting arrangements was as follows:
| (In millions) | As of March 31, 2025 | ||||
|---|---|---|---|---|---|
| Offsetting of Assets | Gross Amounts of Recognized Assets | Gross Amounts Offset in the Consolidated Balance Sheets | Net Presented in the Consolidated Balance Sheets | Amount Subject to Master Netting Agreement | Net Amount |
| Derivatives | $10.6 | $— | $10.6 | $(2.4) | $8.2 |
| (In millions) | As of March 31, 2025 | ||||
|---|---|---|---|---|---|
| Offsetting of Liabilities | Gross Amounts of Recognized Liabilities | Gross Amounts Offset in the Consolidated Balance Sheets | Net Presented in the Consolidated Balance Sheets | Amount Subject to Master Netting Agreement | Net Amount |
| Derivatives | $55.9 | $— | $55.9 | $(2.4) | $53.5 |
| (In millions) | As of December 31, 2024 | ||||
|---|---|---|---|---|---|
| Offsetting of Assets | Gross Amounts of Recognized Assets | Gross Amounts Offset in the Consolidated Balance Sheets | Net Presented in the Consolidated Balance Sheets | Amount Subject to Master Netting Agreement | Net Amount |
| Derivatives | $6.3 | $— | $6.3 | $(1.6) | $4.7 |
| (In millions) | As of December 31, 2024 | ||||
|---|---|---|---|---|---|
| Offsetting of Liabilities | Gross Amounts of Recognized Liabilities | Gross Amounts Offset in the Consolidated Balance Sheets | Net Presented in the Consolidated Balance Sheets | Amount Subject to Master Netting Agreement | Net Amount |
| Derivatives | $44.3 | $— | $44.3 | $(1.6) | $42.7 |
The following table presents the location and amount of the gain (loss) on foreign currency derivatives and on the remeasurement of assets and liabilities denominated in foreign currencies, as well as the net impact recognized in the Condensed Consolidated Statements of Income:
| Derivatives Not Designated as Hedging Instruments · Location of Gain (Loss) Recognized in Income on Derivatives · Amount of Gain (Loss) Recognized in Income | |||
|---|---|---|---|
| Three Months Ended March 31, | |||
| (In millions) · 2025 · 2024 | |||
| Foreign exchange contracts | Revenue | $4.8 | $(3.6) |
| Foreign exchange contracts | Cost of sales | (2.4) | 1.9 |
| Foreign exchange contracts | Selling, general and administrative expense | 2.4 | (0.3) |
| Total | 4.8 | (2.0) | |
| Remeasurement of assets and liabilities in foreign currencies | (2.3) | 0.3 | |
| Net gain (loss) | $2.5 | $(1.7) | |
Interest Rates: The Company has entered into four interest rate swaps executed in March 2020 with a combined notional amount of $200 million which expired in April 2025, andone interest rate swap executed in May 2020 with a notional amount of $50 million expiring in May 2025. These interest rate swaps fix the interest rate applicable to certain of the Company's variable-rate debt. The agreements swap one-month SOFR rates for fixed rates. The Company has designated these swaps as cash flow hedges and all changes in fair value of the swaps are recognized in accumulated other comprehensive income.
At March 31, 2025, the fair value of these derivatives designated as cash flow hedges is recorded in the Condensed Consolidated Balance Sheets as Other current assets of $0.8 million and as Accumulated other comprehensive income, net of tax, of $0.5 million. At December 31, 2024, the fair value of these derivatives designated as cash flow hedges is recorded in the Condensed Consolidated Balance Sheets as Other current assets of $3.0 million and as Accumulated other comprehensive income, net of tax, of $2.1 million.
Fair Value: On January 3, 2025, the Company entered into five cross-currency swaps expiring in January 2032 related to $700 million of the U.S. dollar denominated Term Loan B drawn down by JBT Marel's European entity. These cross currency swap agreements have a combined notional amount of $700 million and synthetically swap interest rates from SOFR to EURIBOR and hedge the impact of variability in exchange rates on the U.S. dollar dominated debt and related interest payments, excluding the credit spread, by our euro-functional entity.
The Company has designated these swaps as fair value hedges and changes in the fair value of these swaps are recognized in earnings in the period realized. The gains and losses related to the change in the fair value of the hedged components of the swaps are included in other income and substantially offset the change in the fair value of the hedged portion of the underlying debt that is attributable to the change in euro to U.S. dollar exchange rates. Changes in fair value of the swaps related to excluded components of the derivative instruments are recognized in accumulated other comprehensive income and recognized into earnings systematically over the life of the hedged instrument.
At March 31, 2025, the fair value of these derivatives designated as fair value hedges were recorded in the Balance Sheet as Other liabilities of $53.5 million and as accumulated other comprehensive income, net of tax, of $18.1 million.
Refer to Note 10. Fair Value Of Financial Instruments for a description of how the values of the above financial instruments are determined.
Credit Risk
By their nature, financial instruments involve risk including credit risk for non-performance by counterparties. Financial instruments that potentially subject the Company to credit risk primarily consist of trade receivables and derivative contracts. The Company manages the credit risk on financial instruments by transacting only with financially secure counterparties, requiring credit approvals and establishing credit limits, and monitoring counterparties’ financial condition. The Company's maximum exposure to credit loss in the event of non-performance by the counterparty, for all receivables and derivative contracts as of March 31, 2025, is limited to the amount drawn and outstanding on the financial instrument. Refer to Note 1. Description of Business and Basis of Presentation in Item 8. Financial Statements and Supplementary Data of the Company's most recent Annual Report on Form 10-K, for a description of how allowance for credit loss is determined on financial assets measured at amortized cost, which includes Trade receivables, Contract assets, and non-current receivables.
NOTE 12. LEASES
The following table provides the required information regarding operating and sales-type leases for which the Company is lessor.
| Three Months EndedMarch 31, | ||
|---|---|---|
| (In millions) | 2025 | 2024 |
| Fixed payment revenue | $15.8 | $16.1 |
| Variable payment revenue | 9.0 | 9.8 |
| Operating lease revenue | $24.8 | $25.9 |
| Sales-type lease revenue | $1.0 | $0.9 |
Refer to Note 16. Related Party Transactions for details of operating lease agreements with related parties.
NOTE 13. COMMITMENTS AND CONTINGENCIES
In the normal course of business, the Company is at times subject to pending and threatened legal actions, some for which the relief or damages sought may be substantial. Although the Company is not able to predict the outcome of such actions, after reviewing all pending and threatened actions with counsel and based on information currently available, management believes that the outcome of such actions, individually or in the aggregate, will not have a material adverse effect on the Company's results of operations or financial position. However, it is possible that the ultimate resolution of such matters, if unfavorable, may be material to its results of operations in a particular future period as the time and amount of any resolution of such actions and its relationship to the future results of operations are not currently known.
Liabilities are established for pending legal claims only when losses associated with the claims are judged to be probable, and the loss can be reasonably estimated. In many lawsuits and arbitration, it is not considered probable that a liability has been incurred or not possible to estimate the ultimate or minimum amount of that liability until the case is close to resolution, in which case no liability would be recognized until that time.
Guarantees and Product Warranties
In the ordinary course of business with customers, vendors and others, the Company issues standby letters of credit, performance bonds, surety bonds and other guarantees. These financial instruments, which totaled $74.6 million at March 31, 2025, represent guarantees of future performance. The Company has also provided approximately $9.4 million of bank guarantees and letters of credit to secure a portion of its existing financial obligations. The majority of these financial instruments expire withinone year and are expected to be replaced through the issuance of new or the extension of existing letters of credit and surety bonds.
In some instances, the Company guarantees its customers’ financing arrangements. The Company is responsible for payment of any unpaid amounts, but will receive indemnification from third parties forninety percent of the contract values. In addition, the Company generally retains recourse to the equipment sold. As of March 31, 2025, the gross value of such arrangements was $2.8 million, of which the Company's net exposure under such guarantees was $0.3 million.
The Company provides warranties of various lengths and terms to certain customers based on standard terms and conditions and negotiated agreements. The Company provides for the estimated cost of warranties at the time revenue is recognized for products where reliable, historical experience of warranty claims and costs exist. The Company also provides a warranty liability when additional specific obligations are identified. The warranty obligation reflected in Other current liabilities in the Condensed Consolidated Balance Sheets is based on historical experience by product and considers failure rates and the related costs in correcting a product failure. Warranty cost and accrual information were as follows:
| Three Months EndedMarch 31, | ||
|---|---|---|
| (In millions) | 2025 | 2024 |
| Balance at beginning of period | $12.2 | $9.9 |
| Expense for new warranties | 2.6 | 2.6 |
| Adjustments to existing accruals | 0.2 | (0.1) |
| Claims paid | (2.3) | (1.8) |
| Added through acquisition | 8.3 | — |
| Translation | 0.5 | (0.1) |
| Balance at end of period | $21.5 | $10.5 |
NOTE 14. BUSINESS SEGMENT INFORMATION
Following the acquisition of Marel on January 2, 2025, the Company has determined that it hastwo reportable segments: the legacy pre-acquisition operations of the Company ("JBT") and the acquired entity of Marel, inclusive of purchase accounting adjustments. The JBT segment provides comprehensive solutions throughout the food production value chain for a variety of food and beverage groups, in addition to providing automated guided vehicle systems. The Marel segment provides advanced processing equipment, systems, software, and services, primarily for the poultry, meat, and fish industries, as well as processing solutions for pet food, plant-based proteins and aqua feed.
The Company is in the process of integrating the businesses and establishing internal reporting capabilities and in the future will realign its reportable segments.
Operating segments for the Company are determined based on information used by the Chief Operating Decision Maker (CODM) in deciding how to evaluate performance and allocate resources to each of the segments. The Company's Chief Executive Officer is the CODM, who uses segment adjusted EBITDA for the purpose of evaluating the financial performance of the segments, making operating decisions, and allocating resources. Additionally, the CODM does not review any information regarding total assets on a segment basis.
Segment profitability measures and significant expenses
The following tables present financial information for the Company's reportable segments and significant expenses regularly provided to the CODM:
| Three Months Ended March 31, 2025 | ||||
|---|---|---|---|---|
| (In millions) · JBT · Marel · Total | ||||
| Total revenue | $408.8 | $445.3 | $854.1 | |
| Less: | ||||
| Cost of sales | 267.9 | 293.7 | 561.6 | |
| Other segment items (1) | 101.6 | 139.3 | 240.9 | |
| Add: | ||||
| Depreciation and amortization | 21.5 | 39.1 | 60.6 | |
| Segment Adjusted EBITDA | $60.8 | $51.4 | $112.2 | |
| Less: | ||||
| Income tax (benefit) provision | $(46.2) | |||
| Interest income | (1.4) | |||
| Interest expense | 42.4 | |||
| Other income | (2.0) | |||
| Pension expense, other than service cost | 146.8 | |||
| Restructuring related costs | 10.6 | |||
| M&A related costs | 74.4 | |||
| Depreciation and amortization | 60.6 | |||
| Income from continuing operations | $(173.0) | |||
| Capital expenditures | $11.8 | $8.2 | $20.0 | |
| Three Months Ended March 31, 2024 | ||||
|---|---|---|---|---|
| (In millions) · JBT · Marel · Total | ||||
| Total revenue | $392.3 | $— | $392.3 | |
| Less: | ||||
| Cost of sales | 252.0 | — | 252.0 | |
| Other segment items (1) | 105.0 | — | 105.0 | |
| Add: | ||||
| Depreciation and amortization | 22.1 | — | 22.1 | |
| Segment Adjusted EBITDA | $57.4 | $— | $57.4 | |
| Less: | ||||
| Income tax (benefit) provision | $8.1 | |||
| Interest income | (5.7) | |||
| Interest expense | 2.9 | |||
| Pension expense, other than service cost | 1.0 | |||
| Restructuring related costs | 1.1 | |||
| M&A related costs | 5.2 | |||
| Depreciation and amortization | 22.1 | |||
| Income from continuing operations | $22.7 | |||
| Capital expenditures | $10.5 | $— | $10.5 | |
(1) Other segment items for each reportable segment include operating expenses, which primarily consist of selling, general and administrative expenses. Other segment items excludes the impact of restructuring related costs, and M&A related costs, which include integration costs, amortization of inventory step-up from business combinations, impacts of foreign currency derivatives and trades to hedge variability of exchange rates on the cash consideration paid for business combination, advisory and transaction costs for both potential and completed M&A transactions and strategy. Restructuring and M&A related costs are excluded as they do not reflect the ongoing operations of the underlying business.
NOTE 15. RESTRUCTURING
Restructuring charges primarily consist of employee separation benefits under existing severance programs, foreign statutory termination benefits, certain one-time termination benefits, contract termination costs, asset impairment charges and other costs that are associated with restructuring actions. Certain restructuring charges are accrued prior to payments made in accordance with applicable guidance. For such charges, the amounts are determined based on estimates prepared at the time the restructuring actions were approved by management. Inventory write offs due to restructuring are reported in Cost of products and all other restructuring charges are reported as Restructuring expenses in the Statements of Income.
In the third quarter of 2022, the Company implemented a restructuring plan (the "2022/2023 restructuring plan") to optimize the overall cost structure for the Company on a global basis. The Company completed the 2022/2023 restructuring plan as of March 31, 2024. The total cost in connection with this plan was $17.5 million.
In the first quarter of 2025, the Company implemented a restructuring plan (the "JBT Marel 2025 Integration restructuring plan") to achieve a portion of its synergy targets as a result of the Marel acquisition to optimize the overall cost structure for the combined Company on a global basis. The initiatives under this plan include streamlining operations and adjusting our general and administrative infrastructure to meet the strategic needs of JBT Marel. As of March 31, 2025, the cost of this plan is $11.1 million and the total estimated cost in connection with this plan is in the range of $25.0 million to $30.0 million for the combined Company expected to be recognized by the end of 2026.
The following table details the cumulative restructuring charges reported in operating (loss) income for the JBT Marel 2025 Integration restructuring plan since its implementation:
| Cumulative Amount | During the Quarter Ended | Cumulative Amount | |
|---|---|---|---|
| (In millions) | Balance as of December 31, 2024 | March 31, 2025 | Balance as of March 31, 2025 |
| Severance and related expense | $— | $11.1 | $11.1 |
| Total restructuring charges, net | $— | $11.1 | $11.1 |
Restructuring charges, net of release of related liability, are reported in Restructuring expense within the Condensed Consolidated Statements of Income. Liability balances for restructuring activities are included in Other current liabilities in the accompanying Condensed Consolidated Balance Sheets. The table below details the activities in 2025 for the JBT Marel 2025 Integration restructuring plan:
| Impact to Earnings | |||||
|---|---|---|---|---|---|
| (In millions) | Balance as of December 31, 2024 | Charged to Earnings | Releases | Cash Payments | Balance as of March 31, 2025 |
| Severance and related expense | $— | $11.1 | $— | $(1.5) | $9.6 |
| Total | $— | $11.1 | $— | $(1.5) | $9.6 |
The Company released $0.5 million of the liability related to the 2022/2023 restructuring plan during the three months ended March 31, 2025, which it no longer expects to pay due to actual severance payments differing from the original estimates and natural attrition of employees.
NOTE 16. RELATED PARTY TRANSACTIONS
The Company is a party to lease agreements to lease manufacturing facilities from entities owned by certain of the Company's employees who were former owners or employees of acquired businesses. As of March 31, 2025, the operating lease right-of- use asset and the lease liability related to these agreements was $2.7 million and $2.8 million, respectively. As of December 31, 2024, the operating lease right-of-use asset and the lease liability related to these agreements was $2.8 million and $2.9 million, respectively.
NOTE 17. SUBSEQUENT EVENTS
In March 2025, the Company entered into a lease agreement for a new global headquarters, which consists of office space of approximately 27,000 sq feet in Chicago, Illinois. The lease term commenced in May 2025 and has a term of 16 years with the option to renew for an additional 5 year term. The Company recognized an ROU asset and lease liability of approximately $4.5 million upon taking control of the premises on the lease commencement. Leasehold improvements on the office space are expected to be completed before the end of the year.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.